Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 37 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 9347951

    Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an immunoglobulin heavy chain constant region

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted May 24, 2016 · Expires May 19, 2036

    granted

  2. US 9340785

    Selective inhibition of polyglutamine protein expression

    The Board of Regents of the University of Texas System · Granted May 17, 2016 · Expires May 12, 2036

    granted

  3. US 9340576

    Methods of treating depression and other related diseases

    Northwestern University · Granted May 17, 2016 · Expires May 12, 2036

    granted

  4. US 9339513

    Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes

    Alnylam Pharmaceuticals, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted

  5. US 9339433

    Methods of diagnosing and treating neonatal reversion to fetal consciousness

    The Regents of the University of California · Granted May 17, 2016 · Expires May 12, 2036

    granted

  6. US 9340777

    Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

    Precision BioSciences, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted

  7. US 9340784

    Methods and compositions for modulating alpha-1-antitrypsin expression

    Ionis Pharmaceuticals, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted

  8. US 9333245

    Methods and compositions for treating wounds and reducing the risk of incisional hernias

    The Regents of the University of California · Granted May 10, 2016 · Expires May 5, 2036

    granted

  9. US 9328391

    Cloning and expression of HIV-1 DNA

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  10. US 9322010

    Fusion molecule based on novel TAA variant

    The Regents of the University of California · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  11. US 9322021

    Methods for modulating kallikrein (KLKB1) expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  12. US 9315813

    Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes

    Alnylam Pharmaceuticals, Inc. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  13. US 9315534

    Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response to Therapy and processes for the preparation of such agents

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  14. US 9315811

    Methods for modulating kallikrein (KLKB1) expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  15. US 9315467

    Compounds for nonsense suppression, and methods for their use

    PTC THERAPEUTICS, INC. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  16. US 9303080

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  17. US 9297015

    Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted

  18. US 9289468

    Fusion protein comprising circularly permuted form of trail/Apo2L, coding gene and use thereof

    Beijing Sunbio Biotech Co. Ltd. · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  19. US 9290562

    Transferrin-tumstatin fusion protein and methods for producing and using the same

    The Regents of the University of Colorado · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  20. US 9284251

    Complex zinc and alpha-chlorocarboxylic acid compounds for treating skin lesions

    OBSCHESTVOS S OGRANITCHENNOI OTVETSTVENNOSTJU “OXYGON” · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted

  21. US 9278161

    Tissue-separating fatty acid adhesion barrier

    ATRIUM MEDICAL CORPORATION · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  22. US 9278066

    Topical pharmaceutical foam composition

    Precision Dermatology, Inc. · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  23. US 9273076

    Compounds for nonsense suppression, and methods for their use

    PTC THERAPEUTICS, INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  24. US 9273315

    Modulation of huntingtin expression

    Ionis Pharmaceuticals, Inc. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.